SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis

BACKGROUND AND AIM: This investigation was aimed at disclosing whether SRPX2 affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling. METHODS: Totally 243 PC patients were recruited, and they were incorporated into partial remission (PR) group, stable disease (SD) group...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhenyuan, Wu, Jisong, Wu, Xiao, Zheng, Jialei, Ou, Yimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718643/
https://www.ncbi.nlm.nih.gov/pubmed/33336063
http://dx.doi.org/10.1515/med-2020-0157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718643/
https://www.ncbi.nlm.nih.gov/pubmed/33336063
http://dx.doi.org/10.1515/med-2020-0157

Ejemplares similares